V Square Quantitative Management LLC Buys 416 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

V Square Quantitative Management LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,762 shares of the healthcare conglomerate’s stock after acquiring an additional 416 shares during the quarter. V Square Quantitative Management LLC’s holdings in UnitedHealth Group were worth $2,915,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of the business. CFC Planning Co LLC purchased a new stake in UnitedHealth Group in the 4th quarter worth approximately $248,000. Littlejohn Financial Services Inc. purchased a new stake in UnitedHealth Group in the 4th quarter worth approximately $2,012,000. Rooted Wealth Advisors Inc. lifted its holdings in UnitedHealth Group by 51.3% in the 4th quarter. Rooted Wealth Advisors Inc. now owns 864 shares of the healthcare conglomerate’s stock worth $444,000 after buying an additional 293 shares during the period. Compagnie Lombard Odier SCmA lifted its holdings in UnitedHealth Group by 10.1% in the 4th quarter. Compagnie Lombard Odier SCmA now owns 37,236 shares of the healthcare conglomerate’s stock worth $18,836,000 after buying an additional 3,427 shares during the period. Finally, Farmers & Merchants Trust Co of Chambersburg PA lifted its holdings in UnitedHealth Group by 31.2% in the 4th quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 1,969 shares of the healthcare conglomerate’s stock worth $996,000 after buying an additional 468 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Wells Fargo & Company lowered their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. KeyCorp restated an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Barclays lowered their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a research note on Friday, January 10th. Finally, Truist Financial lowered their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Stock Performance

Shares of UNH opened at $531.31 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The firm has a market capitalization of $488.96 billion, a P/E ratio of 34.28, a PEG ratio of 1.45 and a beta of 0.61. The business has a fifty day moving average of $524.58 and a 200 day moving average of $563.71.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the previous year, the company posted $5.83 earnings per share. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.